QUANTVEDA
Wave 2 · Upcoming Applications

From reasoning to continuous care

In active development · Not available for clinical use

Wave 1 built 38 products that reason clinically. Wave 2 is a different kind of system — ten applications built around one shared patient state, closed clinical loops, and an evidence ledger that proves care changed the outcome.

Wave 1 · 38 built products

Can we reason clinically at population scale?

A Wave-1 product is done when it reasons correctly.

Wave 2 · 10 upcoming applications

Can we hold one patient's state continuously, act on it across every setting, and prove it changed the outcome?

A Wave-2 product is done when it writes to shared state, closes a loop, and emits evidence.

The distinction changes what “done” means. Done is no longer a correct answer — it is a write to shared state, a closed loop, and an outcome-trackable event.

Architecture

The cascade

Every Wave-2 application reads from and writes to one continuous patient state, and everything that acts emits evidence downstream. The cascade is the product.

AKHANDA Patient State / Clinical Graph
▲ writes
OMNIOME · AI Physician · GUARDIAN+ Reasoning surfaces
Specialty AI Twin (INDRA H-OS) · DRISHTI family Specialty surfaces
◀ read / write ▶
JEEVANA Longitudinal orchestration
ABHAYAED
SEVANursing
GRIHA VYDYAHome / virtual
VYUHAHospital twin
SAATHIPatient
emits evidence ▼
PRAMANA Outcomes / evidence ledger
SANGAMA Federated learning across sites
Model recalibration
DHANVANTARIDiscovery loop

AKHANDA and VYUHA are working names; PRAMANA is under review. Dashed boxes are reasoning and specialty surfaces that read and write the shared state.

Build-order consequence: AKHANDA and PRAMANA are foundational. Every other Wave-2 product depends on at least one of them. They are Priority 1 and 2 for that structural reason.
Portfolio

The ten applications

Ten applications, 1,024 new knowledge bases, four build phases. Three names are provisional pending a final naming decision.

AKHANDA working name

Patient State / Clinical Graph — the one place the patient exists. Sanskrit akhaṇḍa, “unbroken, indivisible”.

Phase A84 KBs

Dependencies: none — foundational; blocks everything downstream.

Read the blueprint →
PRAMANA name under review

Outcomes & Evidence Ledger — proves care changed the outcome. Every Wave-2 product emits to it.

Phase A96 KBs

Dependencies: AKHANDA events.

Blueprint in authoring
JEEVANA

Longitudinal care orchestration — chronic disease trajectories and goals across settings.

Phase B128 KBs

Dependencies: AKHANDA.

Blueprint in authoring
GUARDIAN+

Medication intelligence — recommends and blocks, never prescribes. Extends the built GUARDIAN.

Phase B112 KBs

Dependencies: AKHANDA; extends the built GUARDIAN.

Blueprint in authoring
ABHAYA

Emergency department intelligence — the ED loop of the cascade.

Phase B120 KBs

Dependencies: AKHANDA; integrates SHAYYAA, PRAANA, SUSHRUT.

Blueprint in authoring
SEVA

Nursing workforce intelligence — the nursing layer of the cascade.

Phase C108 KBs

Dependencies: AKHANDA, SHAYYAA.

Blueprint in authoring
GRIHA VYDYA

Home & virtual care — care delivery beyond the hospital walls.

Phase C96 KBs

Dependencies: composes SETU, Aegis, ARES, Twin, SHRAVANI + JEEVANA.

Blueprint in authoring
VYUHA working name

Hospital operational twin — command centre. Sanskrit vyūha, “strategic formation”.

Phase C104 KBs

Dependencies: AAROGYA, SHAYYAA, PRAANA, SUSHRUT, ABHAYA.

Blueprint in authoring
SANGAMA

Federated learning across sites — models travel, data does not.

Phase D72 KBs

Dependencies: PRAMANA.

Blueprint in authoring
SAATHI

Patient companion — the patient-facing surface of the cascade.

Phase D104 KBs

Dependencies: AKHANDA, JEEVANA, GUARDIAN+.

Blueprint in authoring

AKHANDA and VYUHA carry working names pending a final naming decision. PRAMANA (Sanskrit pramāṇa, “proof, means of valid knowledge”) is under review, with SAKSHYA (sākṣya, “evidence, testimony”) as the alternative.

Method

How Wave 2 is built

Knowledge bases come first

Every Wave-2 product is KB-first: knowledge bases are authored, clinically reviewed, and frozen before the engine that consumes them. Every KB carries a claim grade that governs downstream hedging language — frontier-hypothesis content may never appear in a clinician-facing recommendation without an explicit uncertainty banner.

established emerging contested frontier-hypothesis

The layer taxonomy — uniform across all ten products

LayerNameContains
L0OntologyEntities, codes, value sets, units, identity rules
L1Domain KnowledgeClinical facts, guidelines, physiology, thresholds
L2Reasoning TemplatesDecision trees, scoring, trajectory models
L3WorkflowState machines, role handoffs, escalation ladders
L4IntegrationContracts with other QuantVeda products, FHIR mappings
L5Safety & GovernanceProhibitions, red lines, audit rules, consent gates
Every product must have a non-empty L0 and L5. A product with no L5 is not shippable.
The determinism rule

Scores are computed by code. Narratives are generated by the model. These never swap.

A language model never produces a risk score, a dose, a triage category, or a probability. It receives pre-computed values and writes the clinical prose around them. This is mandatory for every Wave-2 product; a violation is a P0 defect.

Event-driven, evidence-emitting

All inter-product communication is event-driven, never direct invocation. Every Wave-2 product must emit to PRAMANA: a product that takes a clinical action and emits no outcome-trackable event is incomplete.

Safety

Seven universal safety rails

Every rail is implemented as code, not prompt instructions, and applies to all ten applications.

Human-in-the-loop gateway

No Wave-2 product issues a clinical instruction to a patient without a licensed clinician's approval event recorded in AKHANDA.

No autonomous prescribing

GUARDIAN+ recommends and blocks; it never prescribes.

Escalation is uninterruptible

Any deterioration signal must reach a human. No queue, rate-limit, or quiet-hours rule may suppress a red-tier alert. SAATHI's quiet hours (22:00–07:00) apply to nudges only, never to alerts.

Consent is per-purpose and revocable

Care delivery, quality improvement, research, and commercial RWE are four separate consents. SANGAMA may only train on the third and fourth.

Provenance on every assertion

Every clinical claim surfaced to a user resolves to a KB id and version. Unattributable output is suppressed.

Degraded mode is defined, not emergent

Every product declares what it does when its dependencies are unavailable. The default is fail-safe: reduce function, never guess.

Paediatric, pregnancy, and geriatric gates

Any dosing or physiological threshold checks life-stage before emitting.

Sequence

Build sequence: Phase A → D

Phase A

Foundational

  • 1 · AKHANDABlocks everything downstream
  • 2 · PRAMANADepends on AKHANDA events
Phase B

Clinical loops

  • 3 · JEEVANADepends on AKHANDA
  • 4 · GUARDIAN+Extends built GUARDIAN; depends on AKHANDA
  • 5 · ABHAYADepends on AKHANDA; integrates SHAYYAA / PRAANA / SUSHRUT
Phase C

Workforce and setting

  • 6 · SEVADepends on AKHANDA, SHAYYAA
  • 7 · GRIHA VYDYAComposes SETU / Aegis / ARES / Twin / SHRAVANI + JEEVANA
  • 8 · VYUHADepends on AAROGYA, SHAYYAA, PRAANA, SUSHRUT, ABHAYA
Phase D

Scale and surface

  • 9 · SANGAMADepends on PRAMANA
  • 10 · SAATHIDepends on AKHANDA, JEEVANA, GUARDIAN+
Sequencing: Phase A must complete before Phase B begins. Phases B and C may overlap. Phase D requires Phase B complete.
1,024
total new knowledge bases across Wave 2 — authored, clinically reviewed, and frozen before the engines that consume them
Definition of done

What “done” means for every product

No Wave-2 product ships until every line below holds.

All KBs authored, clinically reviewed, sealed with hash, versioned
L0 and L5 non-empty and independently reviewed
Relational schema migrated, with triggers and indexes
Business-logic engine passing its full deterministic test suite (100%, no skips)
Zero LLM-computed scores (automated check in CI)
API-connected UI, no simulated data paths remaining in production build
Event contracts published and consumed by at least one downstream product
PRAMANA emission verified end-to-end
Degraded-mode behaviour tested by dependency-kill drill
Life-stage gates tested with paediatric, pregnancy, geriatric fixtures
Monitoring dashboards and alarms live
Clinical sign-off recorded against a named reviewer